4//SEC Filing
WILSON KAREN J 4
Accession 0001567619-21-003192
CIK 0001601485other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:24 PM ET
Size
7.0 KB
Accession
0001567619-21-003192
Insider Transaction Report
Form 4
WILSON KAREN J
Director
Transactions
- Conversion
Common Stock
2021-02-09$11.57/sh+18,718$216,567→ 18,718 total - Conversion
Convertible Promissory Note
2021-02-09→ 0 totalExercise: $16.00→ Common Stock
Footnotes (2)
- [F1]The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock.
- [F2]The convertible promissory note ("Convertible Note") had a maturity date of June 1, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share.
Documents
Issuer
Angion Biomedica Corp.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001267490
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:24 PM ET
- Size
- 7.0 KB